Universe Pharmaceuticals to buy Best Praise for US$10.75 million in stock
PUBT · 3d ago
Share
Listen to the news
- Universe Pharmaceuticals agreed to buy Best Praise International, which holds five China patents with potential pharmaceutical applications.
- Purchase price set at USD 10.75 million, paid with 4,376,552 Class A ordinary shares.
- Patents span elderly healthcare-related areas, including age-related diseases, cognitive and cardiovascular applications, plus antibacterial compounds and drug-delivery technologies.
- Deal is expected to close in the third quarter of 2026, subject to customary closing conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Universe Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606261605PRIMZONEFULLFEED9753039) on June 26, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved